By Amber Murray Medical equipment manufacturer Smith+Nephew has reported 2.9 per cent revenue growth for the first quarter of 2024, in-line with expected growth. Reported revenue growth was slightly lower, at 2.2 per cent, due to foreign exchange headwinds. “Revenue growth in the first quarter was driven by solid performance in our orthopaedics and sports medicine & ENT businesses, partially offset by some anticipated softness in advanced wound management,” Chief Executive Officer Deepak Nath said. Orthopaedic sales grew by 4.4 per cent over the quarter, thanks to “growth in hip and knee impla…